Litcius/Paper detail

EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update

Bernhard Hellmich, Beatriz Sánchez‐Álamo, Jan Henrik Schirmer, Alvise Berti, Daniël Blockmans, María C. Cid, Julia U. Holle, Nicole Hollinger, Ömer Karadağ, Andreas Kronbichler, Mark A. Little, Raashid Luqmani, Alfred Mahr, Peter A. Merkel, Aladdin J Mohammad, Sara Monti, Chetan Mukhtyar, Jacek Musiał, Fiona Price-Kuehne, Mårten Segelmark, Y K Onno Teng, Benjamin Terrier, Gunnar Tómasson, Augusto Vaglio, Dimitrios Vassilopoulos, Peter Verhoeven, David Jayne

2023Annals of the Rheumatic Diseases667 citationsDOIOpen Access PDF

Topics & Concepts

MedicineRituximabMicroscopic polyangiitisAzathioprineGranulomatosis with polyangiitisVasculitisAnti-neutrophil cytoplasmic antibodyPrednisoloneIntensive care medicineInternal medicineANCA-Associated VasculitisClinical trialRheumatologyCyclophosphamideLymphomaChemotherapyDiseaseVasculitis and related conditionsSystemic Sclerosis and Related DiseasesOtitis Media and Relapsing Polychondritis
EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update | Litcius